What's New
Press Releases
Holloway Family Fund Established to Expand AFTD’s Research Initiatives
AFTD today announced the creation of The Holloway Family Fund, supported by an initial $2 million donation from AFTD Board Member Kristin Holloway. The fund, which was created in honor of the Holloway family’s journey with FTD, aims to further…
Landmark $20MM Donation Fuels AFTD’s Work Targeting FTD, Most Common Dementia under 60
AFTD is grateful to announce the creation of The Donald and Susan Newhouse Fund at AFTD. The Fund has been launched through a generous $20 million donation from AFTD donor and passionate volunteer Donald E. Newhouse. Mr. Newhouse’s $20MM gift,…
Target ALS and AFTD Announce $5MM in Grants for Research Targeting Treatments and Biomarkers
Today, Target ALS and AFTD announced $5 million in funding awards for work by six research teams to aid in the discovery of biomarkers and viable treatments for ALS and frontotemporal degeneration. ALS and FTD overlap in genetic causes and…
Communications Strategist Kristin Holloway Joins AFTD’s Board of Directors
Today, The Association for Frontotemporal Degeneration (AFTD) announced that Kristin Holloway has joined its Board of Directors. This appointment was made effective April 18. After experiencing a sequence of unexplained changes in behavior and personality, Ms. Holloway’s husband, Lee Holloway,…
Major Research Funding for Blood Test to Accelerate Clinical Trials for New FTD Therapies
The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) announced today a major funding investment to the Bluefield Project to Cure FTD. The award is the first FTD investment through ADDF’s Diagnostics Accelerator, an initiative aimed to fast…
Fourth Annual AFTD Benefit Raises More Than $2 Million in Support of Frontotemporal Degeneration Research, Support and Awareness
AFTD held its annual Hope Rising Benefit on Wednesday night, raising more than $2 million in support of the organization’s mission. More than 550 attended the event at The Pierre Hotel in New York, including people living with FTD, care…
Target ALS and AFTD Announce Groundbreaking Partnership to Spur Drug and Biomarker Development for ALS and FTD
Today, The Association for Frontotemporal Degeneration (AFTD) and Target ALS announced a groundbreaking partnership and call for proposals to identify treatments and biomarkers for FTD and ALS. These two devastating, progressive diseases are now understood to overlap in genetic causes…
“Days of Our Lives” Star Martha Madison Raises FTD Awareness at Dallas Marathon
A team of 20 taking part in the BMW Dallas Marathon (December 7-9) will run to raise awareness of young-onset dementia and support The Association for Frontotemporal Degeneration, the country’s leading nonprofit focused on FTD. Runners include Texas native and Days of Our Lives star Martha…
Third Annual AFTD Benefit Draws Largest Attendance to Date, Raises over $1.9 Million, in Support of Frontotemporal Degeneration Research, Support and Awareness
AFTD held its annual Hope Rising Benefit on Wednesday, October 17. The benefit drew its highest attendance since the first gala in 2016, and raised more than $1.9MM to fuel AFTD’s mission of advancing FTD research and improving quality of…
New AFTD PSA Produced with Discovery, Inc. Will Bring Awareness of Young-Onset Dementia
A new PSA released by AFTD in partnership with Discovery highlights the challenges faced by families in the wake of an FTD diagnosis. The 30-second video features firsthand testimonials from three individuals whose lives have been touched by FTD; it…